Risk Factors for the Recurrence of Basal Cell Carcinomas with Special Remarks on the R-Status

Background: Surgical excision remains the gold standard in the treatment of operable basal cell carcinoma (BCC). According to national guidelines, total resection with tumor-free margins should always be achieved in order to avoid recurrence. The aim of this study was to investigate surgical, histological as well as tumorspecific risk factors for the recurrence of BCC of the head and neck. Materials and Methods: In a retrospective analysis, patients who were operated on because of a BCC of the head and neck between 2011 and 2014 were included. Epidemiological as well as therapeutic and histological data were collected and investigated concerning the recurrence of the tumor. Follow-up data were controlled for recurrence. Results: 141 patients with a mean age of 72.9 years were included in this study. Most frequent tumor localizations were the nose and temple, and most of the BCC were nodular. Altogether, 8.6% of the patients showed a recurrence. In the chi-squared analysis, R-status or the resection margin did not correlate with the risk of BCC recurrence at the same localization. In contrast, the significant risk factors for recurrence were the tumor localization, size, and histological subtype. Conclusion: Incomplete total resection (R1) of a BCC does not inevitably lead to a recurrence. A reason therefore might be immune-mediated regression, which can be seen in other tumor entities as well. However, a total resection should still always be the aim for surgical therapy, especially for cases with high risk for recurrence.

[1]  H. Husein-ElAhmed Sclerodermiform basal cell carcinoma: how much can we rely on dermatoscopy to differentiate from non-aggressive basal cell carcinomas? Analysis of 1256 cases* , 2018, Anais brasileiros de dermatologia.

[2]  K. Rieger,et al.  Incidence ratio of basal cell carcinoma to squamous cell carcinoma equalizes with age , 2017, Journal of the American Academy of Dermatology.

[3]  B. Dheansa,et al.  Basal cell carcinomata: Risk factors for incomplete excision and results of re-excision. , 2016, Journal of plastic, reconstructive & aesthetic surgery : JPRAS.

[4]  S. Gode,et al.  Long-term Follow-up of Positive Surgical Margins in Basal Cell Carcinoma of the Face , 2015, Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.].

[5]  A. Kauvar,et al.  Consensus for Nonmelanoma Skin Cancer Treatment: Basal Cell Carcinoma, Including a Cost Analysis of Treatment Methods , 2015, Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.].

[6]  Jared W. Garlick,et al.  Surgical Excision of Non–Melanoma Skin Cancer in an Elderly Veteran’s Affairs Population , 2014, Plastic and reconstructive surgery. Global open.

[7]  C. Berking,et al.  Basal cell carcinoma-treatments for the commonest skin cancer. , 2014, Deutsches Arzteblatt international.

[8]  Shiyong Wu,et al.  Retrospective chart review of skin cancer presence in the wide excisions. , 2014, World journal of clinical cases.

[9]  A. Hauschild,et al.  Brief S2k guidelines – Basal cell carcinoma of the skin , 2013, Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG.

[10]  S. Aiba,et al.  Basal Cell Carcinoma with Spontaneous Regression: A Case Report and Immunohistochemical Study , 2012, Case Reports in Dermatology.

[11]  G. Giatsidis,et al.  Facial basal cell carcinoma: analysis of recurrence and follow-up strategies. , 2011, Oncology reports.

[12]  F. Bath-Hextall,et al.  Interventions for basal cell carcinoma of the skin. , 2007, The Cochrane database of systematic reviews.

[13]  J. Rawlins,et al.  Regression of BCC following immunosuppression withdrawal in a renal transplant recipient , 2006, Clinical and experimental dermatology.

[14]  Carmen D Dirksen,et al.  Surgical excision vs Mohs' micrographic surgery for basal-cell carcinoma of the face: randomised controlled trial , 2004, The Lancet.

[15]  F. Bath-Hextall,et al.  Interventions for basal cell carcinoma of the skin: systematic review , 2004, BMJ : British Medical Journal.

[16]  J. Bonnetblanc,et al.  Histological evolution of recurrent basal cell carcinoma and therapeutic implications for incompletely excised lesions , 2004, The British journal of dermatology.

[17]  J. Boldrick,et al.  Effects of biopsy‐induced wound healing on residual basal cell and squamous cell carcinomas: rate of tumor regression in excisional specimens , 2003, Journal of cutaneous pathology.

[18]  S. Fisher,et al.  Recurrent basal cell carcinoma after incomplete resection. , 2000, Archives of dermatology.

[19]  P. Lespi,et al.  Folliculotropic T cells in regressive basal cell carcinoma of skin. , 2000, The American Journal of dermatopathology.

[20]  D. Weedon,et al.  Regression in basal cell carcinoma: an immunohistochemical analysis , 1994, The British journal of dermatology.

[21]  K. Dietz,et al.  Prediction of subclinical tumor infiltration in basal cell carcinoma. , 1991, The Journal of dermatologic surgery and oncology.

[22]  Aleksandar Sekulic,et al.  Basal Cell Skin Cancer, Version 1.2016, NCCN Clinical Practice Guidelines in Oncology. , 2016, Journal of the National Comprehensive Cancer Network : JNCCN.

[23]  C. Kovarik,et al.  Lethal basal cell carcinoma secondary to cerebral invasion. , 2005, Journal of the American Academy of Dermatology.

[24]  D. Kuijpers,et al.  Basal Cell Carcinoma , 2002, American journal of clinical dermatology.